Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease

Experimental Hematology

Volumn 30, Issue 1, 2002, Pages 7-10

  Schleuning, Michael ^a   Stoetzer, Oliver ^a   Waterhouse, Christine ^b   Schlemmer, Markus ^a   Ledderose, Georg ^a   Kolb, Hans Jochem ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CASE REPORT; CHIMERA; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; PROPHYLAXIS; SICKLE CELL ANEMIA; STEM CELL MOBILIZATION;

ADULT; ANEMIA, SICKLE CELL; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE;

RAPHIA FRATER;

EID: 0036142948     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00775-5     Document Type: Article

References (21)

1. Mortality in sickle cell disease. Life expectancy and risk factors for early death
2. Bone marrow transplantation for sickle cell disease
3. Results and current indications of bone marrow allograft in sickle cell disease
4. Harnessing graft-vs-malignancy; nonmyeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy
5. Nonmyeloablative approaches to the treatment of sickle hemoglobinopathies
6. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers
7. Capillary isoelectric focusing and high-performance cation-exchange chromatography compared for qualitative quantitative analysis of hemoglobin variants
8. Bone marrow transplantation in sickle cell anemia
9. Bone marrow transplantation in adult thalassemic patients
10. Impact of bone marrow transplantation for symptomatic sickle cell disease; an interim report
11. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total-body irradiation before and pharmacological immunosuppression after marrow transplantation
12. Mini-allografts; ongoing trials in humans
13. Bone marrow transplantation without myeloablation for sickle cell disease
14. Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease
15. T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-vs-host disease after allogeneic stem cell transplantation
16. + thalassemia
17. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration
18. Recombinant human G-CSF-mobilized peripheral blood stem cells for second allogeneic transplant after bone marrow graft rejection in children
19. Mobilization and apheresis of sickle cell trait (SCT) donors is safe and feasible
20. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers
21. No difference in graft-vs-host disease, relapse, and survival comparing peripheral stem cells to bone marrow unrelated donors